KLOW Blend (GHK-Cu + TB-500 + BPC-157 + KPV)

<span style="font-weight: 400;">KLOW Blend is a multi-peptide formulation combining GHK-Cu(50mg), TB-500(10mg), BPC-157(10mg), and KPV(10mg). It is studied for its potential synergistic effects in reducing inflammation, supporting healing, and promoting skin and tissue health</span> KLOW Blend brings together four peptides that have each been independently studied across regenerative biology, inflammatory pathway, and extracellular matrix research — and each operates through a mechanistically distinct signaling route. <span style="font-weight: 400;">GHK-Cu, the naturally occurring copper tripeptide first isolated from human plasma by Pickart in 1973, is studied for copper-dependent collagen synthesis signaling, MMP/TIMP matrix remodeling balance, and keratinocyte migration activity in skin and connective tissue preparations. BPC-157, a synthetic pentadecapeptide, contributes VEGF-dependent angiogenic signaling through VEGFR2 and FAK phosphorylation pathways. TB-500, the synthetic Thymosin Beta-4 analog, adds VEGF-independent vascular signaling via integrin αvβ3 and Akt-eNOS activation, alongside actin-mediated cell migration facilitation.</span> <span style="font-weight: 400;">KPV — the fourth and newest addition to this formulation — is a tripeptide derived from the C-terminal sequence of α-MSH. Its primary research interest lies in its ability to enter cells via PepT1, a peptide transporter expressed in intestinal epithelial, immune, and mucosal cell preparations, where it directly inhibits NF-κB nuclear translocation and downstream pro-inflammatory cytokine expression.</span> <span style="font-weight: 400;">KLOW Blend addresses inflammatory signaling through two separate pathway entry points simultaneously.</span>

All products are designated Research Use Only (RUO). Not for human consumption. Not a drug, supplement, or food product. Purchasers assume responsibility for compliance with all applicable regulations. By purchasing you confirm you are 21 or older.